Recent biosimilars strategies

Biosimilars square measure medications that claim to possess no clinical variability in purity, potency, and safety. These medications have a big impact on folks with a good vary of unhealthful and grievous diseases, as well as rheumatism, degenerative disorder, leukaemia, lymphomas, internal organ myopathies, and numerous oncogenic cancers.

 

  • Analytical techniques
  • Cancer therapies
  • Cardiovascular therapies
  • Diabetes therapies
  • Cancer therapies
  • Biosimilars: Regulatory Approach

Related Conference of Recent biosimilars strategies

September 11-12, 2024

9th International Conference on Future Pharma and Innovations

Amsterdam, Netherlands
September 25-26, 2024

4th World Congress on Rare Diseases & Orphan Drugs

Paris, France
October 31-01, 2024

37th World Congress on Pharmacology

Amsterdam, Netherlands
November 26-27, 2024

3rd World Congress on Precision and Personalized Medicine

Zurich, Switzerland
November 26-27, 2024

3rd World Conference on Pharma Industry and Medical Devices

Zurich, Switzerland
November 28-29, 2024

12th International Conference on Clinical Trials

Vancouver, Canada
November 28-29, 2024

39th World Congress on Pharmacology and Therapeutics

Paris, France
December 05-06, 2024

17th World Drug Delivery Summit

Dubai, UAE
February 24-25, 2025

2nd International Conference on Pharmacognosy

Madrid, Spain
March 10-11, 2025

35th Annual European Pharma Congress

Rome, Italy
March 13-14, 2025

8th International on Pharmacy and Pharmaceutical Conference

Prague, Czech Republic
April 14-15, 2025

18th European Biosimilars Congress

Paris, France
June 16-17, 2025

3rd Global Online Summit on Nanoscience and Nanotechnology

Zurich, Switzerland

Recent biosimilars strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in